Diseases, Conditions, Syndromes

New dengue vaccine could worsen disease in some people

Drugmaker Sanofi says that its dengue vaccine, the world's first, should only be given to people who have previously been sickened by the virus, according to new long-term data.

Medications

Sanofi buys US flu vaccine maker Protein for $750 mln

French pharmaceuticals giant Sanofi, which is looking to boost its presence in biotechnology, said Tuesday it had agreed to buy the privately-owned US vaccines maker Protein Sciences for up to $750 million (658 million euros).

Medications

US approves Sanofi, Regeneron arthritis drug

US federal regulators have given the green light to French pharmaceutical company Sanofi and its US partner Regeneron to market a drug to treat the chronic inflammatory condition, rheumatoid arthritis.

Diseases, Conditions, Syndromes

First dengue vaccine goes on sale in Guatemala

The world's first vaccine against dengue, a mosquito-borne virus that causes fever and pain and can be fatal, will go on sale in Guatemala within weeks, the French company making it said Tuesday.

Diseases, Conditions, Syndromes

France's Sanofi to work with US Army on Zika vaccine

French pharmaceuticals group Sanofi said Wednesday it would work with the US Army's Walter Reed Institute to develop a potential vaccine against the mosquito-borne Zika virus, linked to brain damage in newborns.

Diseases, Conditions, Syndromes

UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza ...

page 5 from 13